AMJEVITA
NDC 55513-413, adalimumab-atto, injection, from Amgen, Inc.
- Product NDC
- 55513-413
- Status
- Listed
- Labeler
- Amgen, Inc
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761024
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55513-413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADALIMUMAB10 mg/.2mL
Pharmacologic classes
Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55513-413-01 | 55513041301 | 1 SYRINGE in 1 CARTON (55513-413-01) / .2 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9c44bd5b-4464-40a4-8933-8680950f00f2
Use it
Look up 55513-413 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55513-413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55513-413. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.